These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 30677432)
1. Peripheral nervous system effects in the PS19 tau transgenic mouse model of tauopathy. Merchán-Rubira J; Sebastián-Serrano Á; Díaz-Hernández M; Avila J; Hernández F Neurosci Lett; 2019 Apr; 698():204-208. PubMed ID: 30677432 [TBL] [Abstract][Full Text] [Related]
2. Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein. Yin Z; Valkenburg F; Hornix BE; Mantingh-Otter I; Zhou X; Mari M; Reggiori F; Van Dam D; Eggen BJL; De Deyn PP; Boddeke E J Alzheimers Dis; 2017; 60(s1):S41-S57. PubMed ID: 28222529 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467 [TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines. Woerman AL; Patel S; Kazmi SA; Oehler A; Freyman Y; Espiritu L; Cotter R; Castaneda JA; Olson SH; Prusiner SB JAMA Neurol; 2017 Dec; 74(12):1464-1472. PubMed ID: 29059326 [TBL] [Abstract][Full Text] [Related]
6. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy. Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341 [TBL] [Abstract][Full Text] [Related]
7. Progressive age-dependent motor impairment in human tau P301S overexpressing mice. Koivisto H; Ytebrouck E; Carmans S; Naderi R; Miettinen PO; Roucourt B; Tanila H Behav Brain Res; 2019 Dec; 376():112158. PubMed ID: 31442549 [TBL] [Abstract][Full Text] [Related]
8. Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study. Ahmad F; Mein H; Jing Y; Zhang H; Liu P Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575885 [TBL] [Abstract][Full Text] [Related]
9. Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice. Walker CK; Greathouse KM; Boros BD; Poovey EH; Clearman KR; Ramdas R; Muhammad HM; Herskowitz JH Neuroscience; 2021 Feb; 455():195-211. PubMed ID: 33346120 [TBL] [Abstract][Full Text] [Related]
10. Progressive tauopathy in P301S tau transgenic mice is associated with a functional deficit of the olfactory system. Yang S; Kuan WL; Spillantini MG Eur J Neurosci; 2016 Sep; 44(6):2396-403. PubMed ID: 27422327 [TBL] [Abstract][Full Text] [Related]
11. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy. Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917 [TBL] [Abstract][Full Text] [Related]
12. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections. Iba M; McBride JD; Guo JL; Zhang B; Trojanowski JQ; Lee VM Acta Neuropathol; 2015 Sep; 130(3):349-62. PubMed ID: 26150341 [TBL] [Abstract][Full Text] [Related]
13. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies. Wagner J; Krauss S; Shi S; Ryazanov S; Steffen J; Miklitz C; Leonov A; Kleinknecht A; Göricke B; Weishaupt JH; Weckbecker D; Reiner AM; Zinth W; Levin J; Ehninger D; Remy S; Kretzschmar HA; Griesinger C; Giese A; Fuhrmann M Acta Neuropathol; 2015 Nov; 130(5):619-31. PubMed ID: 26439832 [TBL] [Abstract][Full Text] [Related]
14. Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy. Soni DM; Lin PB; Lee-Gosselin A; Lloyd CD; Mason E; Ingraham CM; Perkins A; Moutinho M; Lamb BT; Chu S; Oblak AL Alzheimers Dement; 2024 Jul; 20(7):4985-4998. PubMed ID: 38923171 [TBL] [Abstract][Full Text] [Related]
15. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy. Ono M; Komatsu M; Ji B; Takado Y; Shimojo M; Minamihisamatsu T; Warabi E; Yanagawa T; Matsumoto G; Aoki I; Kanaan NM; Suhara T; Sahara N; Higuchi M Aging Cell; 2022 Jul; 21(7):e13615. PubMed ID: 35662390 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice. Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179 [TBL] [Abstract][Full Text] [Related]
17. Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau. Schweighauser M; Murzin AG; Macdonald J; Lavenir I; Crowther RA; Scheres SHW; Goedert M Acta Neuropathol Commun; 2023 Oct; 11(1):160. PubMed ID: 37798679 [TBL] [Abstract][Full Text] [Related]
18. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993 [TBL] [Abstract][Full Text] [Related]
19. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model. Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072 [TBL] [Abstract][Full Text] [Related]
20. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo. Kaufman SK; Sanders DW; Thomas TL; Ruchinskas AJ; Vaquer-Alicea J; Sharma AM; Miller TM; Diamond MI Neuron; 2016 Nov; 92(4):796-812. PubMed ID: 27974162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]